La evolución de la administración oral de productos biológicos

Durante años, la administración oral de productos biológicos se ha visto como poco práctica. Pero, ¿qué sucede si el problema no es la vía, sino el enfoque?

In our new podcast, Lonza Capsugel’s Vincent Jannin, R&D expert, discusses how using strategies that work with gastrointestinal physiology, rather than fighting against it, opens new possibilities for clinically and commercially viable oral dosage forms.

From peptides to emerging modalities, the conversation challenges long-standing assumptions and highlights how integrated capsule and formulation technologies are redefining what is possible.

Listen to the full discussion and discover how we’re turning oral biologics into strategic opportunity.

* The presented information was correct and current at the time of publication.